The cerebrovascular properties of 3,4,6,7,8,9-hexahydrodibenzo[b,d]furan-1(2H)-one O-(4-cinnamoyl)oxime (C21H21NO3, GIZ-272) were studied. The ability of GIZ-272 to improve the brain blood supply in rats subjected to global transient ischemia and to a lesser extent in animals with a hemorrhagic stroke model was established. The compound had cerebrovascular anti-ischemic activity comparable to that of Mexidol and a duration of action longer than that of nimodipine. It is important to note that GIZ-272 did not cause a decrease in blood pressure and was superior to both Mexidol and nimodipine in this respect. An analysis of the cerebrovascular effect of GIZ-272 using bicucullin indicated that the GABA-ergic system of cerebral vessels participated in implementation of the anti-ischemic effect of the compound.
Similar content being viewed by others
References
E. J. Benjamin, P. Munther, A. Alonso, et al., Circulation, 139(10), e56-e528; doi: https://doi.org/10.1161/CIR.0000000000000659. PMID:30700139.
R. S. Mirzoyan, T. S. Gan’shina, G. A. Kim, et al., Ann. Klin. Eksp. Nevrol., 13(3), 34 – 40 (2019); doi: https://doi.org/10.25692/ACEN.2019.3.5.
S. A. Litvinova, I. S. Kutepova, E. V. Kurza, et al., Eksp. Klin. Farmakol., 82(6), 3 – 7 (2019); doi: https://doi.org/10.30906/0869-2092-2019-82-6-3-7.
I. S. Kutepova, S. A. Litvinova, T. A. Voronina, et al., Eksp. Klin. Farmakol., 82(8), 3 – 8 (2019); doi: https://doi.org/10.30906/0869-2092-2019-82-8-3-8.
R. S. Mirzoyan, M. B. Plotnikov, T. S. Gan’shina, et al., in: Handbook for Preclinical Drug Trials [in Russian], Part 1, Grif i K, Moscow, 2012, pp. 480 – 487.
M. M. Tanashyan, R. N. Konovalov, and O. V. Lagoda, Ann. Klin. Eksp. Nevrol., 12(3), 30 – 39 (2018).
T. Kiris and J. H. Zhang, Acta Neurochir., Suppl. 104, 450 (2008).
I. N. Kurdyumov, T. S. Gan’shina, D. V. Maslennikov, et al., Eksp. Klin. Farmakol., 82(2), 3 – 6 (2019); doi: https://doi.org/10.30906/0869-092-019-82-2-3-6.
R. S. Mirzoyan, T. S. Gan’shina, G. A. Kim, et al., Ann. Klin. Eksp. Nevrol., 12(1), 31 – 37 (2018).
N. R. Mirzoyan, T. S. Gan’shina, I. N. Kurdyumov, and R. S. Bero, Eksp. Klin. Farmakol., 72(2), 17 – 20 (2008).
R. S. Mirzoyan, T. S. Gan’shina, D. V. Maslennikov, et al., BioMed Res. Int., 2014, ID 586501; doi: https://doi.org/10.1155/2014/586501 (2014).
R. S. Mirzoyan, T. S. Gan’shina, A. V. Topchyan, et al., Khim.-farm. Zh., 49(10), 19 – 24 (2015); Pharm. Chem. J., 49(10), 661 – 666 (2015).
G. A. Kim, T. S. Gan’shina, E. V. Vasil?eva, et al., Eksp. Klin. Farmakol., 80(5), 7 – 10 (2017).
R. S. Mirzoyan, T. S. Gan’shina, A. A. Gorbunov, et al., Eksp. Klin. Farmakol., 80(9), 35 – 39 (2017).
T. S. Gan’shina, I. N. Kurdyumov, and E. V. Kurza, Eksp. Klin. Farmakol., 83(1), 3 – 6 (2020); doi: https://doi.org/10.30906/0869-2092-2020-83-1-3-6.
Author information
Authors and Affiliations
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 54, No. 6, pp. 20 – 23, June, 2020.
Rights and permissions
About this article
Cite this article
Mirzoyan, R.S., Gan’shina, T.S., Kurdyumov, I.N. et al. Analysis of the Cerebrovascular Effect of a Dibenzofuran Oxime Derivative. Pharm Chem J 54, 564–567 (2020). https://doi.org/10.1007/s11094-020-02240-9
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-020-02240-9